[ad_1]
Dubai, United Arab Emirates (CNN) – It has been decided to withdraw the drug “metformin”, which is intended for the treatment of diabetes, which is widely used, due to its possible containment of elements that lead to cancer.
Metformin is designed to lower blood sugar in people with type 2 diabetes.
And Kansas City, Missouri, USA-based Nostrum Laboratories Inc. on Monday announced it was voluntarily withdrawing “metformin HCl” tablets, according to the US Food and Drug Administration.
Tests on the drug revealed levels of nitrosamine, or “NDMA”, above the acceptable threshold for the recalled tablets.
The chemical “NDMA” is considered a potential carcinogen by the US Environmental Protection Agency. It is an organic chemical used in the manufacture of liquid rocket fuel and could be a by-product of manufacturing, including the manufacture of drugs.
This is the latest booster of metformin, which is associated with a potentially carcinogenic contaminant in drugs.
The company “Nostrum” said that it had not received any reports of negative events related to the withdrawal of the drug, and the company also said that it is notifying its distributors and arranging the return of the recovered product.
More than 34 million people in the United States have diabetes, or about one in 10 people, with about 90 to 95 percent of them diagnosed with type 2 diabetes, according to the Centers for Disease Control and Prevention. United States.
Source link
